A Q-TWiST analysis comparing panitumumab plus best supportive care (BSC) with BSC alone in patients with wild-type KRAS metastatic colorectal cancer

por Wang, J, Zhao, Z, Barber, B, Sherrill, B, Peeters, M, Wiezorek, J
Publicado 2011

Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment

por Bennett, L, Zhao, Z, Barber, B, Zhou, X, Peeters, M, Zhang, J, Xu, F, Wiezorek, J, Douillard, J-Y
Publicado 2011